subacute myocardial rupture following tirofiban treatment

Subacute Myocardial Rupture Following Tirofiban Treatment

A 74-year-old male patient was admitted to our emergency department with post-MI angina. On account of the anginal complaint that continued for three days, a coronary artery angiography was undertaken. A percutaneous transluminal coronary angioplasty was performed, followed by the implantation of a coronary stent, and coronary perfusion (TIMI-3) was achieved in the left anterior descending arte...

Splenic rupture following thrombolysis treatment for acute myocardial infarction

Thrombolysis is the gold standard of treatment for acute myocardial infarction (MI), however can be associated with haemorrhagic complications. To date, splenic rupture following thrombolysis has only been reported in those with an associated history of major trauma or splenomegaly. We report a case of a 47-year old female who developed splenic rupture following thrombolysis treatment with no h...

Myocardial Rupture following Carbon Monoxide Poisoning

We present the first case of severe cardiotoxicity of carbon monoxide leading to myocardial rupture and fatal outcome. 83-year-old woman was hospitalized 4 hours after the fire in her house with no respiratory or cardiac symptoms. After two days, she has suffered sudden collapse leading to cardiac arrest. Postmortem examination revealed intramural haemorrhage with myocardial rupture at the apex...

Papillary muscle rupture following myocardial infarction.

Alveolar hemorrhage following tirofiban treatment. A misleading diagnosis.

Rev Esp Cardiol. 2010;63(12):1510-6 1511 5. Ailawadi G, LaPar DJ, Swenson BR, Siefert SA, Lau C, Kern JA, et al. Model for end-stage liver disease predicts mortality for tricuspid valve surgery. Ann Thorac Surg. 2009;87:1460-8. 6. Ling LH, Oh JK, Schaff HV, Danielson GK, Mahoney DW, Seward JB, et al. Constrictive pericarditis in the modern era: evolving clinical spectrum and impact on outcome a...

Alveolar Hemorrhage Following Tirofiban Treatment. A Misleading Diagnosis

In clinical trials, very few patients treated with these antiplatelet agents have experienced pulmonary blood loss. Nevertheless, this rate may be underestimated, primarily for under recognition of complication, especially if haemoptysis was not clearly evident.3 The misinterpretation may be due to the striking resemblance on chest x-ray with confounding syndromes, as well as pulmonary edema or...